Canaccord Downgrades DDSS To Hold

Analysts at Canaccord downgrade Labopharm Inc DDSS from “buy” to “hold.” DDSS shares dipped 10.38% to close at $0.733 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DowngradesAnalyst RatingsCanaccordHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!